I. Wildfang

1.2k total citations
27 papers, 810 citations indexed

About

I. Wildfang is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, I. Wildfang has authored 27 papers receiving a total of 810 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Oncology. Recurrent topics in I. Wildfang's work include Management of metastatic bone disease (7 papers), Brain Metastases and Treatment (6 papers) and Spinal Fractures and Fixation Techniques (5 papers). I. Wildfang is often cited by papers focused on Management of metastatic bone disease (7 papers), Brain Metastases and Treatment (6 papers) and Spinal Fractures and Fixation Techniques (5 papers). I. Wildfang collaborates with scholars based in Germany, United States and Netherlands. I. Wildfang's co-authors include Dirk Rades, Johann H. Karstens, Steven E. Schild, Hans‐Joachim Schmoll, Lukas J.A. Stalpers, Winfried Alberti, Fabian Fehlauer, Volker Rudat, Rainer Schulte and Theo Veninga and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

I. Wildfang

27 papers receiving 788 citations

Peers

I. Wildfang
A Goupil France
Dae Sik Hong South Korea
J Kutzner Germany
R E Alison Canada
Robert G. Gagliano United States
Hollon W. Farr United States
John A. Pinkston United States
A Goupil France
I. Wildfang
Citations per year, relative to I. Wildfang I. Wildfang (= 1×) peers A Goupil

Countries citing papers authored by I. Wildfang

Since Specialization
Citations

This map shows the geographic impact of I. Wildfang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Wildfang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Wildfang more than expected).

Fields of papers citing papers by I. Wildfang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Wildfang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Wildfang. The network helps show where I. Wildfang may publish in the future.

Co-authorship network of co-authors of I. Wildfang

This figure shows the co-authorship network connecting the top 25 collaborators of I. Wildfang. A scholar is included among the top collaborators of I. Wildfang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Wildfang. I. Wildfang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Janssen, Stefan, Dirk Rades, Anne Meyer, et al.. (2018). Local recurrence of breast cancer: conventionally fractionated partial external beam re-irradiation with curative intention. Strahlentherapie und Onkologie. 194(9). 806–814. 27 indexed citations
2.
Rades, Dirk, Amira Bajrovic, Hiba Basić, et al.. (2010). Dose Escalation for Metastatic Spinal Cord Compression in Patients With Relatively Radioresistant Tumors. International Journal of Radiation Oncology*Biology*Physics. 80(5). 1492–1497. 25 indexed citations
3.
Wildfang, I., et al.. (2010). Bendamustine and cetuximab as an alternative therapeutic option for recurrent head and neck squamous cell carcinoma.. Journal of Clinical Oncology. 28(15_suppl). e16029–e16029. 2 indexed citations
4.
Rades, Dirk, Peter Hoskin, Lukas J.A. Stalpers, et al.. (2006). Short-course radiotherapy is not optimal for spinal cord compression due to myeloma. International Journal of Radiation Oncology*Biology*Physics. 64(5). 1452–1457. 39 indexed citations
5.
Rades, Dirk, Silke Tribius, Emre F. Yekebas, et al.. (2006). Epoetin alfa improves survival after chemoradiation for Stage III esophageal cancer: Final results of a prospective observational study. International Journal of Radiation Oncology*Biology*Physics. 65(2). 459–465. 22 indexed citations
6.
Macchiarini, Paolo, Tetsuhiko Go, Thorsten Walles, et al.. (2006). Technical Innovations of Carinal Resection for Nonsmall-Cell Lung Cancer. The Annals of Thoracic Surgery. 82(6). 1989–1997. 51 indexed citations
7.
Zardo, Patrick, et al.. (2006). Generation of a bioartificial fibromuscular tissue with autoregenerative capacities for surgical reconstruction. Cytotherapy. 8(2). 178–183. 6 indexed citations
8.
Rades, Dirk, Jochen Walz, Lukas J.A. Stalpers, et al.. (2005). Short-Course Radiotherapy (RT) for Metastatic Spinal Cord Compression (MSCC) Due to Renal Cell Carcinoma: Results of a Retrospective Multi-Center Study. European Urology. 49(5). 846–852. 19 indexed citations
10.
Rades, Dirk, Fabian Fehlauer, Lukas J.A. Stalpers, et al.. (2004). A prospective evaluation of two radiotherapy schedules with 10 versus 20 fractions for the treatment of metastatic spinal cord compression. Cancer. 101(11). 2687–2692. 58 indexed citations
11.
Eckardt, A., Dirk Rades, Volker Rudat, et al.. (2002). Prospektive Phase-II-Studie zur neoadjuvanten Radiochemotherapie fortgeschrittener, operabler Mundhöhlenkarzinome. Mund- Kiefer- und Gesichtschirurgie. 6(2). 117–121. 20 indexed citations
12.
Rades, Dirk, et al.. (2001). Bedeutung der Positronenemissionstomographie (PET) für die Behandlung von Patienten mit unbekanntem Primärtumor (CUP). Strahlentherapie und Onkologie. 177(10). 525–529. 10 indexed citations
13.
Rades, Dirk, et al.. (2001). Localised disease in cancer of unknown primary (CUP): The value of positron emission tomography (PET) for individual therapeutic management. Annals of Oncology. 12(11). 1605–1609. 75 indexed citations
14.
Rades, Dirk, et al.. (2000). Prognostic significance of the time of developing motor deficits before radiation therapy in metastatic spinal cord compression: One-year results of a prospective trial. International Journal of Radiation Oncology*Biology*Physics. 48(5). 1403–1408. 23 indexed citations
15.
Ullrich, D., I. Wildfang, Johann H. Karstens, & M. Schröder. (1999). Nasales T-Zell-Lymphom- Typ letales Mittelliniengranulom. HNO. 47(5). 490–493. 4 indexed citations
16.
Eckardt, A., I. Wildfang, & Johann H. Karstens. (1999). Simultane Radiochemotherapie mit Taxol/Carboplatin bei fortgeschrittenen operablen Kopf-Hals-Tumoren. Strahlentherapie und Onkologie. 175(S3). 11–13. 6 indexed citations
17.
Berkovic, Dinko, et al.. (1997). Synergistic cytotoxic effects of ether phospholipid analogues and ionizing radiation in human carcinoma cells. Radiotherapy and Oncology. 43(3). 293–301. 25 indexed citations
18.
Zeidler, Cornelia, Lothar Kanz, I. Wildfang, et al.. (1992). In vivo effects of interleukin-6 on thrombopoiesis in healthy and irradiated primates [see comments]. Blood. 80(11). 2740–2745. 53 indexed citations
19.
Zeidler, Cornelia, Lothar Kanz, I. Wildfang, et al.. (1992). In vivo effects of interleukin-6 on thrombopoiesis in healthy and irradiated primates [see comments]. Blood. 80(11). 2740–2745. 43 indexed citations
20.
Ovesen, Ole & I. Wildfang. (1990). Foot spas as a cause of burns. Burns. 16(3). 211–213. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026